CoJourney Funding Round

7/11/2023

Venture Equity

$30,000,000

Series A

The company intends to use the funds to expand its US organization and commercial manufacturing capabilities.

Private & Independent

Biopharmaceutical

727 Norristown Road, Building 3 160
Lower Gwynedd, PA 19002
USA

CoJourney is an end-to-end global cell and gene therapy CDMO that integrates the services from process development, cGMP manufacture, analytical methods development, and release testing for plasmids,viral vectors and mRNA. The company is headquartered in Zhejiang and Philadelphia, and operates globally. The company is co-founded by top scientists and senior experts experienced with product commercialization in cell and gene therapy industry. The company has established state-of-the-art plasmid and viral vector cGMP manufacture facilities that meet FDA, EU, NMPA guidelines. CoJourney believes in serving customers with full heart every step of the way. We provide services of plasmid, AAV and mRNA manufacturing, research to cGMP grade, from 10L to 2000L bioreactor scale. Our clinically tested manufacture process provides high quality products with high purity and yield. We want to be a trusted partner in your journey to bring the next transformative medicine to market.